User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

The PanPPAR agonist lanifibranor induces both resolution of NASH and regression of fibrosis after 24 weeks of treatment in non-cirrhotic NASH: results of the NATIVE Phase 2b trial

  • Open access
  • PDF
  • 529.75 K
Bibliographic reference Francque, Sven ; Bedossa, Pierre ; Ratziu, Vlad ; Anstee, Quentin ; Bugianesi, Elisabetta ; et. al. The PanPPAR agonist lanifibranor induces both resolution of NASH and regression of fibrosis after 24 weeks of treatment in non-cirrhotic NASH: results of the NATIVE Phase 2b trial.The Liver Meeting Digital Experience (du 13/11/2020 au 16/11/2020). In: Hepatology, Vol. 72, no.1, p. 9A-11A (2020)
Permanent URL http://hdl.handle.net/2078.1/240678